IRIS
COLOMBO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.577
AS - Asia 2.545
SA - Sud America 826
EU - Europa 634
AF - Africa 69
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.656
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.501
SG - Singapore 1.527
BR - Brasile 713
CN - Cina 594
IE - Irlanda 182
FI - Finlandia 157
VN - Vietnam 116
HK - Hong Kong 75
IT - Italia 58
DE - Germania 54
IN - India 52
GB - Regno Unito 49
AR - Argentina 47
BD - Bangladesh 35
CA - Canada 29
MX - Messico 26
TR - Turchia 26
SE - Svezia 23
ZA - Sudafrica 20
UA - Ucraina 19
FR - Francia 18
EC - Ecuador 17
PL - Polonia 16
IQ - Iraq 15
JP - Giappone 14
PK - Pakistan 13
RU - Federazione Russa 13
CO - Colombia 12
VE - Venezuela 12
ES - Italia 11
NL - Olanda 11
PY - Paraguay 11
MA - Marocco 10
UZ - Uzbekistan 10
NG - Nigeria 9
ID - Indonesia 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 6
CL - Cile 6
DZ - Algeria 6
KE - Kenya 6
PE - Perù 6
AU - Australia 4
DO - Repubblica Dominicana 4
IL - Israele 4
JO - Giordania 4
OM - Oman 4
TW - Taiwan 4
BE - Belgio 3
CR - Costa Rica 3
CY - Cipro 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
HN - Honduras 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PH - Filippine 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
AT - Austria 2
BN - Brunei Darussalam 2
EG - Egitto 2
GE - Georgia 2
JM - Giamaica 2
LT - Lituania 2
MY - Malesia 2
PA - Panama 2
PR - Porto Rico 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
UG - Uganda 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
SV - El Salvador 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.656
Salva come PNG Salva come JPEG
Città #
Ashburn 506
The Dalles 452
Singapore 447
Shanghai 363
New York 207
Boardman 206
Dallas 185
Dublin 182
Helsinki 157
Beijing 87
Los Angeles 75
Hong Kong 74
São Paulo 69
Seattle 39
Chandler 38
Ho Chi Minh City 38
Hanoi 35
Santa Clara 31
Wilmington 23
Council Bluffs 21
Brooklyn 18
Rio de Janeiro 18
Phoenix 17
Brasília 16
Curitiba 16
Pune 16
Warsaw 16
Johannesburg 14
London 13
Chennai 12
Mexico City 12
Tokyo 11
Boston 10
Montreal 10
Benin City 9
Chicago 9
Guarulhos 9
Porto Alegre 9
San Francisco 9
San Mateo 9
Stockholm 9
Assago 8
Atlanta 8
Manaus 8
Manchester 8
Naples 8
Quito 8
Toronto 8
Ankara 7
Belo Horizonte 7
Campo Grande 7
Moscow 7
Baku 6
Caxias do Sul 6
Düsseldorf 6
Guangzhou 6
Lauterbourg 6
Munich 6
Natal 6
Reston 6
Sorocaba 6
Tashkent 6
Uberlândia 6
Amsterdam 5
Ann Arbor 5
Buenos Aires 5
Denver 5
Istanbul 5
Kyiv 5
Marília 5
Nairobi 5
Osasco 5
Recife 5
Rome 5
Salvador 5
Turin 5
Amman 4
Augusta 4
Belford Roxo 4
Biên Hòa 4
Blumenau 4
Charlotte 4
Columbus 4
Cuiabá 4
Dhaka 4
Duque de Caxias 4
Fortaleza 4
Goiânia 4
Ipatinga 4
Joinville 4
Juiz de Fora 4
Lawrence 4
Leawood 4
Lima 4
Londrina 4
Muscat 4
Orem 4
Paris 4
Paulista 4
Petrópolis 4
Totale 3.808
Salva come PNG Salva come JPEG
Nome #
Clinical and Technical Challenges of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation 82
A Propensity Score Matched Comparative Study Between Paclitaxel-Coated Balloon and Everolimus-Eluting Stents for the Treatment of Small Coronary Vessels 80
P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex vs Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials 74
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 67
12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry 59
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 56
Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel 55
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 55
Safety and efficacy of polymer-free drug-eluting stents: Amphilimus-eluting Cre8 versus biolimus-eluting biofreedom stents 55
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 54
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 54
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 53
A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions 52
[Saphenous vein graft aneurysm: percutaneous exclusion using detachable coils] 52
Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection 50
Acute and long-term (2-years) clinical outcomes of the CoreValve 31 mm in large aortic annuli: A multicenter study 50
A Case of Very Late (3 Years) Transcatheter Heart Valve Thrombosis 48
Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysm 47
Advances in percutaneous interventional therapies: The tricuspid valve 45
[40 Years of coronary angioplasty: success comes from skills and determination!] 44
A Novel Technique for Prosthetic Valve Retrieval After Transcatheter Aortic Valve Embolization 44
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 43
[Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration] 43
Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation 42
A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention 42
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis 41
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 41
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry) 40
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 39
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 39
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 38
6 Months’ Follow-Up of the First-in-Man Implantation of a Novel Tricuspid Flow Optimizer 38
The coronary sinus reducer: clinical evidence and technical aspects 37
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation 37
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 37
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials 36
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 36
Impact of coronary artery disease in elderly patients undergoing transcatheter aortic valve implantation: Insight from the Italian CoreValve Registry 36
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 36
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry 36
Which is the best anti-aggregant or anti-coagulant therapy after TAVI? A propensity matched analysis from the ITER registry. The management of DAPT after TAVI 36
Unprotected left main revascularization: Percutaneous coronary intervention versus coronary artery bypass. An updated systematic review and meta-analysis of randomised controlled trials 35
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 35
Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System 35
Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli The TAVI-SMALL Registry 35
Observed versus predicted mortality after MitraClip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation 34
Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches 34
Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge mitraclip technique 34
Feasibility of ultra-low contrast 64-slice computed tomography angiography before transcatheter aortic valve implantation: A real-world experience 34
Multimodality Imaging of a Very Late Thrombosis of a Sutureless Aortic Prosthesis 34
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 33
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 33
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock 33
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease 33
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 33
Intraarterial thrombolysis for treatment of peripheral graft thrombosis: advantage of the radial approach 32
Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: Early results of the feasibility trial 32
Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions 32
Ultrasound-accelerated thrombolysis and extracorporeal membrane oxygenation in a patient with massive pulmonary embolism and cardiac arrest 32
State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey 32
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 32
First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease 32
Prognostic value of tricuspid regurgitation 32
Single-Antiplatelet Therapy in Patients with Contraindication to Dual-Antiplatelet Therapy After Transcatheter Aortic Valve Implantation 32
Dual Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation: Insights From the Milan Cohort 32
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis 32
Impact of crossing strategy on mid-term outcomes following percutaneous revascularisation of coronary chronic total occlusions 31
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 31
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: Development and internal validation of the PSP score 31
Mechanism and Implications of the Tricuspid Regurgitation: From the Pathophysiology to the Current and Future Therapeutic Options 31
Repeat MitraClip for early recurrent mitral regurgitation 31
Anesthetic Management of Cardioband Implantation: Data From a Preliminary Experience and New Insights 31
New therapeutic options for the treatment of tricuspid regurgitation 31
A Fully Percutaneous Transeptal Transcatheter Mitral Valve Replacement With a Novel Device 31
Prognostic implications of the relationship between effective regurgitant orifice area and left ventricle end diastolic volume in patients with functional mitral regurgitation treated with MitraClip 31
Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom 31
Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data Analysis 31
The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris 30
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 30
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry 30
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 30
Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience 30
Coronary sinus Reducer non-responders: insights and perspectives 30
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction 30
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 30
Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational study 30
Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access: A Multicenter Prospective Study 29
Impact of glycaemic and lipid control on outcome after percutaneous coronary interventions in diabetic patients 29
Right ventricular evaluation to improve survival outcome in patients with severe functional mitral regurgitation and advanced heart failure undergoing MitraClip therapy 29
Relation of various plasma growth factor levels in patients with stable angina pectoris and total occlusion of a coronary artery to the degree of coronary collaterals 29
Identification of High-Risk Patients after ST-Segment-Elevation Myocardial Infarction 29
Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound 29
Procedural and longer-term outcomes of wire- versus device-based antegrade dissection and re-entry techniques for the percutaneous revascularization of coronary chronic total occlusions 29
Hybrid Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffolds in Combination With Drug-Eluting Stents or Drug-Coated Balloons for Complex Coronary Lesions 29
Stent loss during chronic total occlusion percutaneous coronary intervention: Optical coherence tomography-guided stent 'crushing and trapping' 29
The Evolution From Surgery to Percutaneous Mitral Valve Interventions The Role of the Edge-to-Edge Technique 29
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 29
Long term follow-up after balloon expandable covered stents implantation for management of transcatheter aortic valve replacement related vascular access complications 29
Transradial versus transfemoral ancillary approach in complex structural, coronary, and peripheral interventions. Results from the multicenter ancillary registry: A study of the Italian Radial Club 29
ONE-YEAR CLINICAL OUTCOMES FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) WITH BOTH EDWARDS SAPIEN AND COREVALVE DEVICES IN A SINGLE CENTER: THE MILAN EXPERIENCE 28
Totale 3.792
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.362
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 14 8 2 9 0 0 3
2021/202222 1 0 0 6 0 0 1 5 0 1 7 1
2022/2023402 9 4 8 24 22 11 2 10 48 38 208 18
2023/20241.691 107 80 389 140 131 315 79 73 26 55 134 162
2024/20252.327 71 5 7 37 53 308 162 129 466 623 256 210
2025/20262.390 917 412 276 501 215 69 0 0 0 0 0 0
Totale 6.870